Kumud Kalia - 04 Mar 2026 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Information Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Kumud Kalia
Issuer symbol
GH
Transactions as of
04 Mar 2026
Net transactions value
-$3,812,661
Form type
4
Filing time
05 Mar 2026, 17:44:17 UTC
Previous filing
05 Jan 2026
Next filing
13 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kalia Kumud Chief Information Officer 3100 HANOVER STREET, PALO ALTO /s/ John G. Saia, as attorney-in-fact for Kumud Kalia 05 Mar 2026 0001927831

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise +2,119 +6.1% $47.20* 36,643 04 Mar 2026 Direct
transaction GH Common Stock Options Exercise +15,000 +41% $47.20* 51,643 04 Mar 2026 Direct
transaction GH Common Stock Options Exercise +1,000 +1.9% $74.00* 52,643 04 Mar 2026 Direct
transaction GH Common Stock Options Exercise +5,000 +9.5% $32.86* 57,643 04 Mar 2026 Direct
transaction GH Common Stock Options Exercise +10,000 +17% $28.37* 67,643 04 Mar 2026 Direct
transaction GH Common Stock Options Exercise +10,000 +15% $28.61* 77,643 04 Mar 2026 Direct
transaction GH Common Stock Sale $2,566,311 -26,980 -35% $95.12 50,663 04 Mar 2026 Direct F1
transaction GH Common Stock Sale $1,246,350 -13,020 -26% $95.73 37,643 04 Mar 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Stock Option (Right to Buy) Options Exercise -2,119 -4.1% $0.000000* 49,305 04 Mar 2026 Common Stock 2,119 $47.20 Direct F3
transaction GH Stock Option (Right to Buy) Options Exercise -15,000 -30% $0.000000* 34,305 04 Mar 2026 Common Stock 15,000 $47.20 Direct F3
transaction GH Stock Option (Right to Buy) Options Exercise -1,000 -3.5% $0.000000* 27,670 04 Mar 2026 Common Stock 1,000 $74.00 Direct F4
transaction GH Stock Option (Right to Buy) Options Exercise -5,000 -44% $0.000000* 6,414 04 Mar 2026 Common Stock 5,000 $32.86 Direct F5
transaction GH Stock Option (Right to Buy) Options Exercise -10,000 -52% $0.000000* 9,410 04 Mar 2026 Common Stock 10,000 $28.37 Direct F6
transaction GH Stock Option (Right to Buy) Options Exercise -10,000 -28% $0.000000* 25,721 04 Mar 2026 Common Stock 10,000 $28.61 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $94.460 to $95.455. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $95.46 to $96.14. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 This represents a stock option award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on November 7, 2023 and the remaining 75% of the shares vests in equal monthly installments over the remaining three-year period thereafter.
F4 This represents a stock option award granted on April 20, 2020 that vests over a four-year period. 25% of the shares subject to such award vested on January 7, 2021 and the remaining 75% of the shares vested in equal monthly installments over the three-year period thereafter.
F5 This represents a stock option award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 9, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.
F6 This represents a stock option award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.
F7 This represents a stock option award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.